Clinical Trial: Mass Balance and Absolute Bioavailability of [14C]-VH4011499

U.S., Nov. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07934719) titled 'Mass Balance and Absolute Bioavailability of [14C]-VH4011499' on Nov. 06.

Brief Summary: The purpose of the trial is to characterize the absorption, metabolism, and excretion of [14C]-VH4011499, and to evaluate the absolute bioavailability of VH4011499.

Study Start Date: Nov. 09

Study Type: INTERVENTIONAL

Condition: HIV Infections

Intervention: DRUG: VH4011499

VH4011499 will be administered orally.

DRUG: [14C]-VH4011499 (IV)

[14C]-VH4011499 will be administered as an iv infusion.

DRUG: [14C]-VH4011499 (oral)

[14C]-VH4011499 will be administered orally.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: ViiV Healthcare

Pub...